Business
AstraZeneca expects COVID variant vaccine by mid to late 2021 – Al Jazeera English
The drug company says it expects an updated COVID-19 vaccine targeting new variants to be ready for use this year.
AstraZeneca has said it expects to have a new version of its COVID-19 vaccine ready for use by mid to late 2021, responding to concerns about emerging variants of the disease that may be more transmissible or resistant to existing vaccines.
The Anglo-Swedish company, which makes a vaccine developed by the University of Oxford, said on Thursday that researchers began the work on the updates months ago when the new variants were first detected.
Were moving fast and weve got a number of variant versions…
Continue Reading
